UCB to undergo major restructuring

Discussion in 'UCB Pharma' started by anonymous, May 16, 2019 at 6:54 PM.

Tags: Add Tags
Page 2 of 2
  1. #21 anonymous, Aug 5, 2019 at 6:09 PM
    anonymous

    anonymous Guest

    What drug is SK coming out with?
     
    Quote

  2. #22 anonymous, Aug 31, 2019 at 11:41 PM
    anonymous

    anonymous Guest


    FDA to Review Cenobamate for the Treatment of Partial-Onset Seizures - Neurology Advisor

    It's Cenobomate. SK will market in the USA while Arvelle will market ROW.

    Do you guys remember when we were screaming about the opportunity this drug had for UCB back in 2015 but the goons in Braine kept saying it was a shit drug? Thanks Benoit Kenda, yet another great decision you advocated for.
     
    Quote
Reply to Thread
Page 2 of 2